Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

eHealth (EHTH) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for eHealth (EHTH) over the last 17 years, with Q3 2025 value amounting to -$1.3 million.

  • eHealth's Cash from Financing Activities fell 18355.56% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.8 million, marking a year-over-year decrease of 2958.25%. This contributed to the annual value of -$9.7 million for FY2024, which is 5543.06% down from last year.
  • Per eHealth's latest filing, its Cash from Financing Activities stood at -$1.3 million for Q3 2025, which was down 18355.56% from -$3.8 million recorded in Q2 2025.
  • eHealth's Cash from Financing Activities' 5-year high stood at $215.9 million during Q2 2021, with a 5-year trough of -$5.0 million in Q4 2024.
  • Its 5-year average for Cash from Financing Activities is $13.4 million, with a median of -$892000.0 in 2023.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first surged by 611848.34% in 2021, then tumbled by 49923.33% in 2023.
  • Over the past 5 years, eHealth's Cash from Financing Activities (Quarter) stood at $2.3 million in 2021, then tumbled by 60.76% to $913000.0 in 2022, then crashed by 499.23% to -$3.6 million in 2023, then crashed by 36.71% to -$5.0 million in 2024, then soared by 74.39% to -$1.3 million in 2025.
  • Its Cash from Financing Activities was -$1.3 million in Q3 2025, compared to -$3.8 million in Q2 2025 and -$699000.0 in Q1 2025.